Advanced search
Publication Cover
Expert Review of Clinical Immunology Volume 13, 2017 - Issue 10
Submit an article Journal homepage
1,432
Views
70
CrossRef citations to date
0
Altmetric
Review

Immunotherapy of cancers comes of age

Hila YousefiResearch Center for Immunodeficiencies, Children’s Medical Center, Tehran University of Medical Sciences, Tehran, Iran;Department of Endodontics, Dental Branch, Tehran Azad University, Tehran, IranView further author information
,
Jianda YuanMemorial Sloan Kettering Cancer Center, New York, NY, USAView further author information
,
Mahsa Keshavarz-FathiResearch Center for Immunodeficiencies, Children’s Medical Center, Tehran University of Medical Sciences, Tehran, Iran;Cancer Immunology Project (CIP), Universal Scientific Education and Research Network (USERN), Tehran, Iran;Students’ Scientific Research Center, Tehran University of Medical Sciences, Tehran, IranView further author information
,
Joseph F MurphyCharles River Laboratories, Wilmington, MA, USAView further author information
&
Nima RezaeiResearch Center for Immunodeficiencies, Children’s Medical Center, Tehran University of Medical Sciences, Tehran, Iran;Department of Immunology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran;Network of Immunity in Infection, Malignancy and Autoimmunity (NIIMA), Universal Scientific Education and Research Network (USERN), Boston, MA, USACorrespondence[email protected]
View further author information
Pages 1001-1015 | Received 14 May 2016, Accepted 08 Aug 2017, Published online: 23 Aug 2017

Citations (70)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Xinge Sheng, Jingyuan Lu, Jiaqi Wang, Kaiwen Fan, Meijiao Huang & Quanyi Lu. (2023) Construction of a prognostic model of acute myeloid leukemia associated with immunogenic cell death. Expert Review of Hematology 16:7, pages 543-551.
Read now
Qiliang Yin, Ying Wang, Yipeng Xiang & Feng Xu. (2022) Nanovaccines: Merits, and diverse roles in boosting antitumor immune responses. Human Vaccines & Immunotherapeutics 18:6.
Read now
Maryam Balibegloo & Nima Rezaei. (2020) Development and clinical application of bispecific antibody in the treatment of colorectal cancer. Expert Review of Clinical Immunology 16:7, pages 689-709.
Read now

Articles from other publishers (67)

Boyu Sun, Ziyu Xun, Nan Zhang, Kai Liu, Xiangqi Chen & Haitao Zhao. (2023) Single-cell RNA sequencing in cancer research: discovering novel biomarkers and therapeutic targets for immune checkpoint blockade. Cancer Cell International 23:1.
Crossref
Akbar Hasanzadeh, Arefeh Ebadati, Lida Dastanpour, Amir R. Aref, Parham Sahandi Zangabad, Alireza Kalbasi, Xiaofeng Dai, Geeta Mehta, Amir Ghasemi, Yousef Fatahi, Suhasini Joshi, Michael R. Hamblin & Mahdi Karimi. (2023) Applications of Innovation Technologies for Personalized Cancer Medicine: Stem Cells and Gene-Editing Tools. ACS Pharmacology & Translational Science 6:12, pages 1758-1779.
Crossref
Parisa Shiri Aghbash, Reyhaneh Rasizadeh, Amir Hossein Yari, Shiva Lahouti, Habib MotieGhader, Javid Sadri Nahand, Taher Entezari-Maleki & Hossein Bannazadeh Baghi. (2023) Interleukin-2 and Oncolytic Virotherapy: A New Perspective in Cancer Therapy. Anti-Cancer Agents in Medicinal Chemistry 23:18, pages 2008-2026.
Crossref
Xiaojuan Zhang, Chuanchuan He, Xuelian He, Sijun Fan, Baoyue Ding, Yao Lu & Guangya Xiang. (2023) HIF-1 inhibitor-based one-stone-two-birds strategy for enhanced cancer chemodynamic-immunotherapy. Journal of Controlled Release 356, pages 649-662.
Crossref
Long Chen, Hongwei Liu, Yanwen Li, Xuelei Lin, Shunjin Xia, Siyi Wanggou & Xuejun Li. (2023) Functional characterization of TSPAN7 as a novel indicator for immunotherapy in glioma. Frontiers in Immunology 14.
Crossref
Jin Zhou, Hai-Ping Lin, Xin Xu, Xiao-Hang Wang, Ling Rong, Yao Zhang, Lei Shen, Lei Xu, Wei-Ting Qin, Qing Ye, Xiu-Mei Ma & Yong-Rui Bai. (2022) The predictive value of peripheral blood cells and lymphocyte subsets in oesophageal squamous cell cancer patients with neoadjuvant chemoradiotherapy. Frontiers in Immunology 13.
Crossref
Ming Zhang, Tingju Wei, Xiaodan Zhang & Danfeng Guo. (2022) Targeting lipid metabolism reprogramming of immunocytes in response to the tumor microenvironment stressor: A potential approach for tumor therapy. Frontiers in Immunology 13.
Crossref
Bingyu Wang & Bibo Tan. (2022) Noncoding RNAs: Regulating the crosstalk between tumor-associated macrophages and gastrointestinal cancer. Biomedicine & Pharmacotherapy 153, pages 113370.
Crossref
Hong-Li Wang, Zhi-Gang Wang & Shu-Lin Liu. (2022) Lipid Nanoparticles for mRNA Delivery to Enhance Cancer Immunotherapy. Molecules 27:17, pages 5607.
Crossref
Abdullah K. Alshememry, Nasser B. Alsaleh, Nora Alkhudair, Rami Alzhrani & Aws Alshamsan. (2022) Recent nanotechnology advancements to treat multidrug-resistance pancreatic cancer: Pre-clinical and clinical overview. Frontiers in Pharmacology 13.
Crossref
Mosar Corrêa Rodrigues, José Athayde Vasconcelos Morais, Rayane Ganassin, Giulia Rosa Tavares Oliveira, Fabiana Chagas Costa, Amanda Alencar Cabral Morais, Ariane Pandolfo Silveira, Victor Carlos Mello Silva, João Paulo Figueiró Longo & Luis Alexandre Muehlmann. (2022) An Overview on Immunogenic Cell Death in Cancer Biology and Therapy. Pharmaceutics 14:8, pages 1564.
Crossref
Tianwen Yin, Peiliang Wang, Jinming Yu & Feifei Teng. (2022) Treatment-related lymphopenia impairs the treatment response of anti-PD-1 therapy in esophageal squamous cell carcinoma. International Immunopharmacology 106, pages 108623.
Crossref
Nah Ihm Kim, Min Ho Park, NamKi Cho & Ji Shin Lee. (2022) Comparison of the Clinicopathologic Features and T-Cell Infiltration of B7-H3 and B7-H4 Expression in Triple-negative Breast Cancer Subtypes. Applied Immunohistochemistry & Molecular Morphology 30:4, pages 246-256.
Crossref
Mengling Wu, Qianrui Huang, Yao Xie, Xuyi Wu, Hongbo Ma, Yiwen Zhang & Yong Xia. (2022) Improvement of the anticancer efficacy of PD-1/PD-L1 blockade via combination therapy and PD-L1 regulation. Journal of Hematology & Oncology 15:1.
Crossref
Binfen Shao, Xuehui Huang, Funeng Xu, Jingmei Pan, Yi Wang & Shaobing Zhou. (2021) A pH-responsive polymersome depleting regulatory T cells and blocking A2A receptor for cancer immunotherapy. Nano Research 15:3, pages 2324-2334.
Crossref
Thai Minh Duy Le, A-Rum Yoon, Thavasyappan Thambi & Chae-Ok Yun. (2022) Polymeric Systems for Cancer Immunotherapy: A Review. Frontiers in Immunology 13.
Crossref
Bandar Hamad Aloufi. (2022) Structure-based Multi-targeted Molecular Docking and Molecular Dynamic Simulation Analysis to Identify Potential Inhibitors against Ovarian Cancer. Journal Of Biochemical Technology 13:2, pages 29-39.
Crossref
Gabriel Pasquarelli-do-Nascimento, Sabrina Azevedo Machado, Juliana Maria Andrade de Carvalho & Kelly Grace Magalhães. (2022) Obesity and adipose tissue impact on T-cell response and cancer immune checkpoint blockade therapy. Immunotherapy Advances 2:1.
Crossref
Neeraj Chhabra & Joseph Kennedy. (2021) A Review of Cancer Immunotherapy Toxicity II: Adoptive Cellular Therapies, Kinase Inhibitors, Monoclonal Antibodies, and Oncolytic Viruses. Journal of Medical Toxicology 18:1, pages 43-55.
Crossref
Rubén Rodríguez-Bautista, Claudia H. Caro-Sánchez, Paula Cabrera-Galeana, Gerardo J. Alanis-Funes, Everardo Gutierrez-Millán, Santiago Ávila-Ríos, Margarita Matías-Florentino, Gustavo Reyes-Terán, José Díaz-Chávez, Cynthia Villarreal-Garza, Norma Y. Hernández-Pedro, Alette Ortega-Gómez, Luis Lara-Mejía, Claudia Rangel-Escareño & Oscar Arrieta. (2021) Immune Milieu and Genomic Alterations Set the Triple-Negative Breast Cancer Immunomodulatory Subtype Tumor Behavior. Cancers 13:24, pages 6256.
Crossref
Qingle Song, Amaneh Javid, Guofang Zhang & Yang Li. (2021) Applications of Magnetite Nanoparticles in Cancer Immunotherapies: Present Hallmarks and Future Perspectives. Frontiers in Immunology 12.
Crossref
Priyanka Verma, Saikat Biswas, Nitin Yadav, Anjali Khatri, Hamda Siddiqui, Jiban Jyoti Panda, Bhupendra Singh Rawat, Prafullakumar Tailor & Virander Singh Chauhan. (2021) Delivery of a Cancer-Testis Antigen-Derived Peptide Using Conformationally Restricted Dipeptide-Based Self-Assembled Nanotubes. Molecular Pharmaceutics 18:10, pages 3832-3842.
Crossref
Neeraj Chhabra & Joseph Kennedy. (2021) A Review of Cancer Immunotherapy Toxicity: Immune Checkpoint Inhibitors. Journal of Medical Toxicology 17:4, pages 411-424.
Crossref
Vahid Mansouri, Nima Beheshtizadeh, Maliheh Gharibshahian, Leila Sabouri, Mohammad Varzandeh & Nima Rezaei. (2021) Recent advances in regenerative medicine strategies for cancer treatment. Biomedicine & Pharmacotherapy 141, pages 111875.
Crossref
Náthali Felícia Mineiro dos Santos Garrett, Ana Cristina Carvalho da Costa, Elaine Barros Ferreira, Giovanni Damiani, Paula Elaine Diniz dos Reis & Christiane Inocêncio Vasques. (2021) Prevalence of dermatological toxicities in patients with melanoma undergoing immunotherapy: Systematic review and meta-analysis. PLOS ONE 16:8, pages e0255716.
Crossref
Clemens Grassberger, Daniel Shinnick, Beow Y. Yeap, Mark Tracy, Susannah G. Ellsworth, Clayton B. Hess, Elizabeth A. Weyman, Sara L. Gallotto, Miranda P. Lawell, Benjamin Bajaj, David H. Ebb, Myrsini Ioakeim-Ioannidou, Jay S. Loeffler, Shannon M. MacDonald, Nancy J. Tarbell & Torunn I. Yock. (2021) Circulating Lymphocyte Counts Early During Radiation Therapy Are Associated With Recurrence in Pediatric Medulloblastoma. International Journal of Radiation Oncology*Biology*Physics 110:4, pages 1044-1052.
Crossref
Mona Sadeghalvad & Nima Rezaei. 2021. Monoclonal Antibodies. Monoclonal Antibodies.
Minglu Zhou, Chaohui Luo, Zhou Zhou, Lian Li & Yuan Huang. (2021) Improving anti-PD-L1 therapy in triple negative breast cancer by polymer-enhanced immunogenic cell death and CXCR4 blockade. Journal of Controlled Release 334, pages 248-262.
Crossref
Yan Dong, Lina Lin, Chumei Zeng, Zhonghui He & Hong Xu. (2021) CD3D has the Potential to be a Prognostic Factor for Endometrial Carcinoma and an Indicator of Tumor Immune Microenvironment Regulation: a Study based on TCGA Data Mining. Indian Journal of Gynecologic Oncology 19:1.
Crossref
Xiaoxiao Liu, Zhang Li & Yuexiang Wang. (2021) Advances in Targeted Therapy and Immunotherapy for Pancreatic Cancer. Advanced Biology 5:3, pages 1900236.
Crossref
Quan Liu, Yanhong Duo, Jianye Fu, Meng Qiu, Zhe Sun, Dickson Adah, Jianlong Kang, Zhongjian Xie, Taojian Fan, Shiyun Bao, Han Zhang, Li-Ping Liu & Yihai Cao. (2021) Nano-immunotherapy: Unique mechanisms of nanomaterials in synergizing cancer immunotherapy. Nano Today 36, pages 101023.
Crossref
Anna Danilova, Vsevolod Misyurin, Aleksei Novik, Dmitry Girdyuk, Natalia Avdonkina, Tatiana Nekhaeva, Natalia Emelyanova, Nino Pipia, Andrey Misyurin & Irina Baldueva. (2020) Cancer/testis antigens expression during cultivation of melanoma and soft tissue sarcoma cells. Clinical Sarcoma Research 10:1.
Crossref
Nah Ihm Kim, Min Ho Park & Ji Shin Lee. (2020) Associations of B7-H3 and B7-H4 Expression in Ductal Carcinoma In Situ of the Breast With Clinicopathologic Features and T-Cell Infiltration. Applied Immunohistochemistry & Molecular Morphology 28:10, pages 767-775.
Crossref
Sheng Zheng, Ning Zhu, Cheng Shi & Heng Zheng. (2020) Genomic data mining approaches for the discovery of anticancer peptides from Ganoderma sinense. Phytochemistry 179, pages 112466.
Crossref
Yuwei Li, Yinan Shen, Tianyu Tang, Zengwei Tang, Wei Song, Zifan Yang, Xiaozhen Zhang, Meng Wang, Xueli Bai & Tingbo Liang. (2020) Oncolytic virus combined with traditional treatment versus traditional treatment alone in patients with cancer: a meta-analysis. International Journal of Clinical Oncology 25:11, pages 1901-1913.
Crossref
Hadiseh Rezazadeh, Mojgan Astaneh, Mohsen Tehrani, Hadi Hossein-Nataj, Ehsan Zaboli, Ramin Shekarriz & Hossein Asgarian-Omran. (2020) Blockade of PD-1 and TIM-3 immune checkpoints fails to restore the function of exhausted CD8+ T cells in early clinical stages of chronic lymphocytic leukemia. Immunologic Research 68:5, pages 269-279.
Crossref
Sitanshu S. Singh, Achyut Dahal, Leeza Shrestha & Seetharama D. Jois. (2020) Genotype Driven Therapy for Non-Small Cell Lung Cancer: Resistance, Pan Inhibitors and Immunotherapy. Current Medicinal Chemistry 27:32, pages 5274-5316.
Crossref
Steven De Almeida, Mathilde Regimbeau, Gaëtan Jego, Carmen Garrido, François Girodon & François Hermetet. (2020) Heat Shock Proteins and PD-1/PD-L1 as Potential Therapeutic Targets in Myeloproliferative Neoplasms. Cancers 12:9, pages 2592.
Crossref
Peter Abdou, Zejun Wang, Qian Chen, Amanda Chan, Daojia R. Zhou, Vivienne Gunadhi & Zhen Gu. (2020) Advances in engineering local drug delivery systems for cancer immunotherapy. WIREs Nanomedicine and Nanobiotechnology 12:5.
Crossref
Shi Zhou & Haijun Zhang. (2020) Synergies of Targeting Angiogenesis and Immune Checkpoints in Cancer: From Mechanism to Clinical Applications. Anti-Cancer Agents in Medicinal Chemistry 20:7, pages 768-776.
Crossref
Wei-min Yin, Yu-wei Li, Yun-qing Gu & Min Luo. (2020) Nanoengineered targeting strategy for cancer immunotherapy. Acta Pharmacologica Sinica 41:7, pages 902-910.
Crossref
Xin Wang, Zongxing Zhao, Peiliang Wang, Xiaotao Geng, Liqiong Zhu & Minghuan Li. (2020) Low Lymphocyte Count Is Associated With Radiotherapy Parameters and Affects the Outcomes of Esophageal Squamous Cell Carcinoma Patients. Frontiers in Oncology 10.
Crossref
Yu-Chen Chuang, Jen-Chih Tseng, Li-Rung Huang, Chun-Ming Huang, Chi-Ying F. Huang & Tsung-Hsien Chuang. (2020) Adjuvant Effect of Toll-Like Receptor 9 Activation on Cancer Immunotherapy Using Checkpoint Blockade. Frontiers in Immunology 11.
Crossref
Matthew J. Woodall, Silke Neumann, Katrin Campbell, Sharon T. Pattison & Sarah L. Young. (2020) The Effects of Obesity on Anti-Cancer Immunity and Cancer Immunotherapy. Cancers 12:5, pages 1230.
Crossref
Bing Feng, Zifei Niu, Bo Hou, Lei Zhou, Yaping Li & Haijun Yu. (2019) Enhancing Triple Negative Breast Cancer Immunotherapy by ICG‐Templated Self‐Assembly of Paclitaxel Nanoparticles. Advanced Functional Materials 30:6.
Crossref
Xin Wang, Peiliang Wang, Zongxing Zhao, Qingfeng Mao, Jinming Yu & Minghuan Li. (2020) A review of radiation-induced lymphopenia in patients with esophageal cancer: an immunological perspective for radiotherapy. Therapeutic Advances in Medical Oncology 12, pages 175883592092682.
Crossref
Nah Ihm Kim, Min Ho Park, Sun-Seog Kweon & Ji Shin Lee. (2020) B7-H3 and B7-H4 Expression in Breast Cancer and Their Association with Clinicopathological Variables and T Cell Infiltration. Pathobiology 87:3, pages 179-192.
Crossref
Maryam Ebadi, Mahsa Keshavarz-Fathi, Yi Zeng, Maria Gkotzamanidou & Nima Rezaei. 2020. Cancer Immunology. Cancer Immunology 135 157 .
Melanie R. Power Coombs & David W. Hoskin. 2020. T-Cell Receptor Signaling. T-Cell Receptor Signaling 161 173 .
Jing Shi, Chen Chen, Rui Ju, Qingzhu Wang, Juan Li, Lei Guo, Caiying Ye & Dechang Zhang. (2019) Carboxyamidotriazole combined with IDO1-Kyn-AhR pathway inhibitors profoundly enhances cancer immunotherapy. Journal for ImmunoTherapy of Cancer 7:1.
Crossref
Xiaoling Xie, Yiran Chen, Yuxing Hu, Yanjie He, Honghao Zhang & Yuhua Li. (2019) Lenalidomide Augments the Antitumor Activities of Eps8 Peptide-Specific Cytotoxic T Lymphocytes against Multiple Myeloma. Molecular Cancer Therapeutics 18:12, pages 2258-2269.
Crossref
Chung-Yih Wang, Chun-Yuan Chang, Chun-Yu Wang, Kaili Liu, Chia-Yun Kang, Yi-Jang Lee & Wei R. Chen. (2019) N-Dihydrogalactochitosan Potentiates the Radiosensitivity of Liver Metastatic Tumor Cells Originated from Murine Breast Tumors. International Journal of Molecular Sciences 20:22, pages 5581.
Crossref
Faezeh Ghaemdoust, Mahsa Keshavarz-Fathi & Nima Rezaei. (2019) Natural killer cells and cancer therapy, what we know and where we are going. Immunotherapy 11:14, pages 1231-1251.
Crossref
Bing Feng, Bo Hou, Zhiai Xu, Madiha Saeed, Haijun Yu & Yaping Li. (2019) Self‐Amplified Drug Delivery with Light‐Inducible Nanocargoes to Enhance Cancer Immunotherapy. Advanced Materials 31:40, pages 1902960.
Crossref
Michael R. Eledge, Marcelle Dina Zita & Karl W. Boehme. (2019) Reovirus: Friend and Foe. Current Clinical Microbiology Reports 6:3, pages 132-138.
Crossref
Sara Charmsaz, Denis Collins, Antoinette Perry & Maria Prencipe. (2019) Novel Strategies for Cancer Treatment: Highlights from the 55th IACR Annual Conference. Cancers 11:8, pages 1125.
Crossref
Linda Zhong, Peijing Yan, Wai Ching Lam, Liang Yao & Zhaoxiang Bian. (2019) Coriolus Versicolor and Ganoderma Lucidum Related Natural Products as an Adjunct Therapy for Cancers: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Frontiers in Pharmacology 10.
Crossref
Xiaoli Wang, Ning Wang, Ying Yang, Xiaoxiao Wang, Jiayi Liang, Xinxin Tian, Hailing Zhang & Xigang Leng. (2019) Polydopamine nanoparticles carrying tumor cell lysate as a potential vaccine for colorectal cancer immunotherapy. Biomaterials Science 7:7, pages 3062-3075.
Crossref
Qiuchen Qi, Yanhong Hou, Ang Li, Yueyue Sun, Siying Li & Zhongxi Zhao. (2019) Yifei Tongluo, a Chinese Herbal Formula, Suppresses Tumor Growth and Metastasis and Exerts Immunomodulatory Effect in Lewis Lung Carcinoma Mice. Molecules 24:4, pages 731.
Crossref
Fang Chen, Joseph A. Fraietta, Carl H. June, Zhongwei Xu, J. Joseph Melenhorst & Simon F. Lacey. (2019) Engineered T Cell Therapies from a Drug Development Viewpoint. Engineering 5:1, pages 140-149.
Crossref
Shiman Wu, Wenli Yang, Hua Zhang, Yan Ren, Ziwei Fang, Chengjie Yuan & Zhenwei Yao. (2019) The Prognostic Landscape of Tumor-Infiltrating Immune Cells and Immune Checkpoints in Glioblastoma. Technology in Cancer Research & Treatment 18, pages 153303381986994.
Crossref
Mahsa Keshavarz-Fathi & Nima Rezaei. 2019. Vaccines for Cancer Immunotherapy. Vaccines for Cancer Immunotherapy 81 89 .
Mahsa Keshavarz-Fathi & Nima Rezaei. 2019. Vaccines for Cancer Immunotherapy. Vaccines for Cancer Immunotherapy 19 44 .
Ga-Eon Kim, Nah Ihm Kim, Min Ho Park & Ji Shin Lee. (2018) B7-H3 and B7-H4 expression in phyllodes tumors of the breast detected by RNA in situ hybridization and immunohistochemistry: Association with clinicopathological features and T-cell infiltration. Tumor Biology 40:11, pages 101042831881503.
Crossref
Fabio Morandi, Francesco Frassoni, Mirco Ponzoni & Chiara Brignole. (2018) Novel Immunotherapeutic Approaches for Neuroblastoma and Malignant Melanoma. Journal of Immunology Research 2018, pages 1-12.
Crossref
Mark Owyong, Gizem Efe, Michael Owyong, Aamna J. Abbasi, Vaishnavi Sitarama & Vicki Plaks. (2018) Overcoming Barriers of Age to Enhance Efficacy of Cancer Immunotherapy: The Clout of the Extracellular Matrix. Frontiers in Cell and Developmental Biology 6.
Crossref
Nathan Singh, Junwei Shi, Carl H. June & Marco Ruella. (2017) Genome-Editing Technologies in Adoptive T Cell Immunotherapy for Cancer. Current Hematologic Malignancy Reports 12:6, pages 522-529.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.